Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.44B |
| 2 |
Microsoft
MSFT
|
+$556M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$433M |
| 4 |
Johnson & Johnson
JNJ
|
+$349M |
| 5 |
Amazon
AMZN
|
+$340M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$873M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$799M |
| 3 |
Colgate-Palmolive
CL
|
+$602M |
| 4 |
Palo Alto Networks
PANW
|
+$574M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$405M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.33% |
| 2 | Financials | 13.77% |
| 3 | Healthcare | 12.44% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Southside Bancshares
SBSI
$974M
| $372K | ﹤0.01% |
10,512
-2,544
| -19% | -$97.6K |
|
2752
Liquidity Services
LQDT
$1.31B
| $370K | ﹤0.01% |
22,733
-26,899
| -54% | -$473K |
|
|
DPCS
2753
DELISTED
DP Cap Acquisition Corp I Class A Ordinary Shares
DPCS
| $369K | ﹤0.01% |
36,522
| – | – |
|
|
ADAP
2754
DELISTED
Adaptimmune Therapeutics
ADAP
| $366K | ﹤0.01% |
340,068
+87,386
| +35% | +$161K |
|
2755
National Beverage
FIZZ
$2.99B
| $366K | ﹤0.01% |
9,484
+2,203
| +30% | +$110K |
|
2756
PROG Holdings
PRG
$1.73B
| $365K | ﹤0.01% |
24,344
-26,440
| -52% | -$496K |
|
|
TIGR
2757
UP Fintech Holding
TIGR
$847M
| $364K | ﹤0.01% |
110,776
-273,556
| -71% | -$1.04M |
|
2758
Wolverine World Wide
WWW
$1.56B
| $364K | ﹤0.01% |
23,611
-1,494
| -6% | -$30.8K |
|
2759
Design Therapeutics
DSGN
$862M
| $361K | ﹤0.01% |
21,598
-183,967
| -89% | -$3.66M |
|
2760
NeoGenomics
NEO
$2B
| $361K | ﹤0.01% |
41,891
-1,596,434
| -97% | -$15.9M |
|
|
NAGE
2761
Niagen Bioscience
NAGE
$241M
| $361K | ﹤0.01% |
293,769
| – | – |
|
2762
CTS Corp
CTS
$1.89B
| $359K | ﹤0.01% |
8,622
-1,714
| -17% | -$68.8K |
|
2763
Miller Industries
MLR
$620M
| $357K | ﹤0.01% |
16,771
+2,668
| +19% | +$61.7K |
|
2764
Toyota
TM
$222B
| $357K | ﹤0.01% |
2,747
-9,393
| -77% | -$1.42M |
|
2765
TFI International
TFII
$11.3B
| $356K | ﹤0.01% |
3,928
+1,068
| +37% | +$104K |
|
2766
Petco
WOOF
$791M
| $356K | ﹤0.01% |
31,825
+12,334
| +63% | +$180K |
|
2767
Blue Owl Capital
OWL
$7.74B
| $355K | ﹤0.01% |
38,501
-67,767
| -64% | -$753K |
|
2768
iShares US Medical Devices ETF
IHI
$3.36B
| $354K | ﹤0.01% |
7,495
-2,935
| -28% | -$152K |
|
|
CCRN
2769
DELISTED
Cross Country Healthcare
CCRN
| $352K | ﹤0.01% |
12,418
-10,917
| -47% | -$281K |
|
|
ROCC
2770
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $350K | ﹤0.01% |
11,134
+1,677
| +18% | +$59K |
|
2771
Algonquin Power & Utilities
AQN
$4.43B
| $348K | ﹤0.01% |
31,912
+9,174
| +40% | +$124K |
|
2772
Compass Minerals
CMP
$1.08B
| $348K | ﹤0.01% |
9,037
-14,129
| -61% | -$539K |
|
2773
Kadant
KAI
$3.95B
| $348K | ﹤0.01% |
2,088
-288
| -12% | -$53.6K |
|
|
RETA
2774
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $348K | ﹤0.01% |
13,862
-1,769
| -11% | -$49K |
|
|
HSKA
2775
DELISTED
Heska Corp
HSKA
| $347K | ﹤0.01% |
4,767
-67
| -1% | -$5.92K |
|
Similar funds
Barclays's Q3 2022 Portfolio in Review
As of Q3 2022, Barclays held 5,400 positions worth $91.6B, down 44% from $163B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $66.4B in Q3 2022, closing 532 positions and reducing 1,954 holdings. Its most notable exit was Vonage Holdings Corporation, an estimated $99.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Barclays opened a new position in Pacer iPath Gold ETNs worth $27.1M.
- Barclays's largest Q3 2022 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $27.1M.
- Barclays added most to Apple in Q3 2022, an estimated $1.44B increase.
- Barclays's biggest Q3 2022 reduction was Invesco QQQ Trust, cutting an estimated $873M.
- Barclays fully exited Vonage Holdings Corporation in Q3 2022, selling an estimated $99.4M.
- Barclays's ten largest holdings make up 22% of its $91.6B portfolio in Q3 2022.
- Barclays opened 261 new positions and closed 532 in Q3 2022.
- Barclays's portfolio value fell 44% quarter-over-quarter to $91.6B.
Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.